These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 9657438)
1. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain. Kavlie A; Orning L; Grindflek A; Stormorken H; Prydz H Thromb Haemost; 1998 Jun; 79(6):1136-43. PubMed ID: 9657438 [TBL] [Abstract][Full Text] [Related]
2. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s). Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Peyvandi F; Jenkins PV; Mannucci PM; Billio A; Zeinali S; Perkins SJ; Perry DJ Thromb Haemost; 2000 Aug; 84(2):250-7. PubMed ID: 10959697 [TBL] [Abstract][Full Text] [Related]
4. Severe factor VII deficiency caused by a novel mutation His348 to Gln in the catalytic domain. Katsumi A; Matsushita T; Yamazaki T; Sugiura I; Kojima T; Saito H Thromb Haemost; 2000 Feb; 83(2):239-43. PubMed ID: 10739380 [TBL] [Abstract][Full Text] [Related]
5. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain. D'Andrea G; Bossone A; Lupone MR; Peyvandi F; Maisto G; Perricone F; Grandone E; Margaglione M Haematologica; 2004 Aug; 89(8):979-84. PubMed ID: 15339682 [TBL] [Abstract][Full Text] [Related]
7. Characterization of porcine factor VII, X and comparison with human factor VII, X. Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401 [TBL] [Abstract][Full Text] [Related]
8. Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg(247) (CGC) in the catalytic domain. Ohiwa M; Hayashi T; Wada H; Minamikawa K; Shirakawa S; Suzuki K Thromb Haemost; 1994 Jun; 71(6):773-7. PubMed ID: 7974346 [TBL] [Abstract][Full Text] [Related]
9. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor. Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729 [TBL] [Abstract][Full Text] [Related]
10. Inherited factor VII deficiency: identification of two novel mutations (A191V and T239P) in the catalytic domain. Borensztajn K; Chafa O; Le Bonniec B; Wajcman H; Reghis A; Fischer AM; Tapon-Bretaudière J Thromb Res; 2005; 116(2):115-20. PubMed ID: 15907525 [TBL] [Abstract][Full Text] [Related]
11. Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency. Zheng XW; Kudaravalli R; Russell TT; DiMichele DM; Gibb C; Russell JE; Margaritis P; Pollak ES Blood Coagul Fibrinolysis; 2011 Oct; 22(7):624-7. PubMed ID: 21760481 [TBL] [Abstract][Full Text] [Related]
12. Twenty two novel mutations of the factor VII gene in factor VII deficiency. Wulff K; Herrmann FH Hum Mutat; 2000; 15(6):489-96. PubMed ID: 10862079 [TBL] [Abstract][Full Text] [Related]
13. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity. Jin J; Perera L; Stafford D; Pedersen L J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356 [TBL] [Abstract][Full Text] [Related]
14. [Novel double heterozygous mutations on Met306Val and Thr181Asn related to a hereditary coagulation factor VII deficiency]. Tu CQ; Deng CY; Wu JZ; Pan CY; Xie CY Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):124-7. PubMed ID: 16620721 [TBL] [Abstract][Full Text] [Related]
16. Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency. Tanaka R; Nakashima D; Suzuki A; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Yamamoto K; Katsumi A; Matsushita T; Naoe T; Kojima T Thromb Res; 2010 Mar; 125(3):262-6. PubMed ID: 19822353 [TBL] [Abstract][Full Text] [Related]
17. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity. Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558 [TBL] [Abstract][Full Text] [Related]
18. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Rodrigues DN; Siqueira LH; Galizoni AM; Arruda VR; Annichino-Bizzacchi JM Blood Coagul Fibrinolysis; 2003 Apr; 14(3):289-92. PubMed ID: 12695753 [TBL] [Abstract][Full Text] [Related]
20. Solution structure of the N-terminal EGF-like domain from human factor VII. Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]